These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 327069)

  • 1. Differences in antischistosomal and mutagenic properties between an isothiocyano- and an isocyanonitrodiphenylamine.
    Coulter AW; Bueding E; Batzinger RP
    J Med Chem; 1977 Jul; 20(7):981-2. PubMed ID: 327069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540).
    Bueding E; Batzinger R; Petterson G
    Experientia; 1976 May; 32(5):604-6. PubMed ID: 1278309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the antischistosomal action and toxicity of phenyl 4-nitro-diphenylamino-4'-thioncarbamate (7720)].
    Quan YZ; Huang WY; Zhou QX; Li YZ
    Yao Xue Xue Bao; 1982 Jul; 17(7):481-6. PubMed ID: 7180477
    [No Abstract]   [Full Text] [Related]  

  • 4. Recovery of the hepatic drug-metabolizing capacity in mice infected with Schistosoma mansoni following curative chemotherapy with the schistosomicide 4-isothiocyano-4'-nitro-diphenylamine (CGP 4540).
    Cha YN; Bueding E
    Am J Trop Med Hyg; 1978 Nov; 27(6):1188-91. PubMed ID: 727323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activation of an antischistosomal drug by enteric Streptococcus sps in vitro and in vivo.
    Molineaux CJ; Batzinger RP; Schmidt W; Bueding E
    Teratog Carcinog Mutagen; 1980; 1(2):129-39. PubMed ID: 6119805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental therapy and mechanism of action of nithiocyamine on Schistosoma japonica].
    Yu HZ
    Yao Xue Xue Bao; 1981 Sep; 16(9):641-7. PubMed ID: 7331811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phenithionate(phenyl-4-nitrodiphenylamine-4'-thionocarbamate) in the treatment of schistosomiasis japonicum--a preliminary report on 463 cases].
    Liu YH
    Zhonghua Nei Ke Za Zhi; 1982 Oct; 21(10):609-13. PubMed ID: 7151549
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of the mutagenic activation of an antischistosomal isothiocyanate in primates by an antibiotic.
    Batzinger RP; Bueding E; Crawford K; Bruce J
    Environ Mutagen; 1979; 1(4):353-60. PubMed ID: 553807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of amoscanate derivatives in experimental schistosomiasis].
    Yue WJ; Shao BR; Pan QR; You JQ; Mei JY
    Yao Xue Xue Bao; 1983 Jul; 18(7):541-4. PubMed ID: 6659959
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of amoscanate against experimental schistosomal infections in monkeys.
    Crawford KA; Asch HL; Bruce JI; Bueding E; Smith ER
    Am J Trop Med Hyg; 1983 Sep; 32(5):1055-64. PubMed ID: 6625061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological changes elicited in Schistosoma japonicum infected rabbits following curative chemotherapy with 4-isothiocyano-4'-nitro-diphenylamine (C9333-Go/CGP 4540).
    Robinson A; Lewert RM
    Trans R Soc Trop Med Hyg; 1981; 75(3):415-7. PubMed ID: 7324109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of a mutagenic drug metabolite by intestinal microorganisms.
    Batzinger RP; Bueding E; Reddy BS; Weisburger JH
    Cancer Res; 1978 Mar; 38(3):608-12. PubMed ID: 414832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunoassay for an antischistosomal drug, 4-nitro-4'-isothiocyano-diphenylamine (7505) (author's transl)].
    Wang ZT; Wang DN; Li Q; Ouyang HJ
    Yao Xue Xue Bao; 1980 Aug; 15(8):463-9. PubMed ID: 7211390
    [No Abstract]   [Full Text] [Related]  

  • 14. Microsomal activation to mutagens of antischistosomal methyl thioxanthenones and initial tests on a possibly non-mutagenic analogue.
    Hartman PE; Hulbert PB; Bueding E; Taylor DD
    Mutat Res; 1975 Apr; 31(2):87-95. PubMed ID: 235087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenithionate in schistosomiasis japonica. Preliminary report of 463 cases.
    Liu YH; Wang QN; Wang XG; Zhan QD; Lu XE; Ma YX; Liu ZL
    Chin Med J (Engl); 1983 Apr; 96(4):269-74. PubMed ID: 6413140
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical observation on schistosomiasis japonica treated with amoscanate and phenithionate in a hyperendemic area].
    Zhou GX
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):634-5. PubMed ID: 6673935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radioimmunoassay of phenithionate (7720) and its clinical application].
    Tian YW
    Zhonghua Nei Ke Za Zhi; 1984 May; 23(5):281-3. PubMed ID: 6489024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study on pyquiton and nithiocyamin in treating Schistosomiasis japonica (author's transl)].
    Chen MG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3(2):134-5. PubMed ID: 6458409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sythesis and antischistosomal action of phenithionate and related derivatives of thiocarbamic acid].
    Yan XH; Li JS; Chen BY; Qiu ZY
    Yao Xue Xue Bao; 1982 Sep; 17(9):667-73. PubMed ID: 7158351
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion of amoscanate to a mutagenic metabolite in gnotobiotic mice implanted with Streptococcus equinus.
    Reddy BS; Batzinger RP; Molineaux CJ; Bueding E
    Antimicrob Agents Chemother; 1982 Oct; 22(4):707-8. PubMed ID: 7181482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.